Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | ALNY | BGNE | ||
| Company | Biomarin Pharmaceuticals | Alnylam Pharmaceuticals | Beigene Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 82.33 | 144.08 | 152.11 | ||
| High | 83.09 | 146.07 | 154.47 | ||
| Low | 80.90 | 143.00 | 150.73 | ||
| Last | 80.91 | 143.31 | 153.58 | ||
| Change | -1.26 | -0.40 | +5.02 | ||
| % Change | -1.53% | -0.28% | +3.38% | ||
| Volume | 2,257,100 | 479,100 | 208,400 | ||
| 20-Day Average Volume | 1,809,910 | 491,800 | 183,420 | ||
| Previous Close | 82.17 | 143.71 | 148.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 88.60 | 148.86 | 144.35 | ||
| 20-Day Raw Stochastic | 0.08% | 7.69% | 82.21% | ||
| 20-Day Relative Strength | 35.33% | 37.65% | 52.77% | ||
| Weighted Alpha | -17.27 | -30.42 | -36.97 | ||
| Today's Opinion | 72% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 64% Sell | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 48% Sell | 88% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.71% since 04/19/24 | -0.76% since 04/19/24 | +18.58% since 04/19/24 | ||
| Low | 80.90 on 04/26/24 | 141.98 on 04/25/24 | 129.96 on 04/22/24 | ||
| High | 93.01 on 04/24/24 | 150.27 on 04/23/24 | 154.47 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | -7.78% since 03/26/24 | -5.70% since 03/26/24 | -0.15% since 03/26/24 | ||
| Low | 80.90 on 04/26/24 | 141.98 on 04/25/24 | 126.97 on 04/19/24 | ||
| High | 93.36 on 04/15/24 | 159.34 on 04/09/24 | 159.34 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -10.96% since 01/26/24 | -20.21% since 01/26/24 | -5.14% since 01/26/24 | ||
| Low | 80.90 on 04/26/24 | 141.98 on 04/25/24 | 126.97 on 04/19/24 | ||
| High | 94.15 on 02/23/24 | 181.66 on 01/30/24 | 184.80 on 03/13/24 | ||
| 6-Month | |||||
| %Chg | -1.29% since 10/26/23 | -7.93% since 10/26/23 | -7.40% since 10/26/23 | ||
| Low | 76.02 on 11/02/23 | 141.98 on 04/25/24 | 126.97 on 04/19/24 | ||
| High | 99.56 on 12/14/23 | 199.38 on 01/09/24 | 205.40 on 11/14/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,270,468 | 18,049,320 | 14,688,390 | ||
| Shares Outstanding, K | 188,734 | 125,946 | 95,640 | ||
| Annual Sales | 2,419,230,000 | 1,828,290,000 | 2,458,780,000 | ||
| Annual Net Income | 167,650,000 | -440,240,000 | -881,710,000 | ||
| Last Quarter Sales | 646,210,000 | 439,720,000 | 634,410,000 | ||
| Last Quarter Net Income | 20,380,000 | -137,870,000 | -367,550,000 | ||
| 60-Month Beta | 0.31 | 0.39 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.71 on 04/24/24 | -1.10 on 02/15/24 | -3.53 on 02/26/24 | ||
| Latest Earnings Date | 04/24/24 | 05/02/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 60.87 | 0.00 | 0.00 | ||